This book gives a comprehensive overview of disease-modifying
antirheumatic drugs (DMARDs). The introductory general chapters deal
with the chemistry of DMARDs, their use in therapy, pharmacoeconomics,
and a survey of opinion leaders in the field; the following specific
chapters characterize each agent with regard to mechanism of action,
therapy, pharmacology, efficacy, toxicity, and monitoring. For each
agent some background is given, recent developments and influence of the
treatment on patients` quality of life and long-term outcomes are
presented.